The Serine Threonine Kinase Cyclin G-Associated Kinase Regulates

Total Page:16

File Type:pdf, Size:1020Kb

The Serine Threonine Kinase Cyclin G-Associated Kinase Regulates The serine͞threonine kinase cyclin G-associated kinase regulates epidermal growth factor receptor signaling Lei Zhang, Ole Gjoerup, and Thomas M. Roberts*† Department of Cancer Biology, Dana–Farber Cancer Institute, and Department of Pathology, Harvard Medical School, Boston, MA 02115 Communicated by R. John Collier, Harvard Medical School, Boston, MA, May 5, 2004 (received for review March 18, 2004) Cyclin G-associated kinase (GAK) is a serine͞threonine kinase that activated by autophosphorylation, internalized, at least in part features high homology outside its kinase domain with auxilin. through clathrin-mediated endocytosis, and sorted to early, and Like auxilin, GAK has been shown to be a cofactor for uncoating subsequently, late endosomes (13–16). Internalized receptors then clathrin vesicles in vitro. We investigated epidermal growth factor are delivered to the lysosome and degraded or recycled to the cell (EGF) receptor-mediated signaling in cells, in which GAK is down- surface. As the receptor transits this three-dimensional path regulated by small hairpin RNAs. Here, we report that down- through the cell’s interior, various EGF-mediated signaling mole- regulation of GAK by small hairpin RNA has two pronounced cules are activated including extracellular signal-regulated kinases effects on EGF receptor signaling: (i) the levels of receptor expres- 1͞2 (ERK1͞2) via the Ras͞raf pathway (11, 17–21), and Akt via the sion and tyrosine kinase activity go up by >50-fold; and (ii) the phosphatidylinositol 3-kinase pathway (22–24). Previous studies spectrum of downstream signaling is significantly changed. One have indicated that blocking receptor trafficking at a particular very obvious result is a large increase in the levels of activated point can have significant effects on receptor signaling. For in- extracellular signal-regulated kinase 5 and Akt. These two effects stance, studies by Vieira et al. (25) showed that expression of a of GAK down-regulation result from, at least in part, alterations in dominant negative allele of dynamin, a GTPase involved in clathrin- receptor trafficking, the most striking of which is the persistence of coated vesicle fission, inhibits endocytosis of EGFR, and con- EGF receptor in altered cellular compartment along with activated sequently, ERK1͞2 activation is attenuated. However, the roles extracellular signal-regulated kinase 5. The alterations resulting of trafficking events subsequent to formation of clathrin-coated from GAK down-regulation can have distinctive biological conse- vesicles in the regulation of EGFR signaling remain relatively quences: In CV1P cells, down-regulation of GAK results in out- unknown. growth of cells in soft agar, raising the possibility that loss of GAK In the present report, we examine the effects of down-regulating function may promote tumorigenesis. GAK expression upon EGFR signaling. By using small hairpin RNA to reduce GAK levels by Ͼ90%, we find that both the levels yclin G-associated kinase (GAK), also known as auxilin II (1, of EGFR in the cells and the signaling downstream from the C2), is a 160-kDa protein, which is highly homologous to receptor are strikingly altered. At least some of these dramatic auxilin I, with the notable exception of a kinase domain found changes are likely due to changes in receptor trafficking. At the at the N terminus of GAK, and totally absent in auxilin I. Unlike biological level, GAK down-regulation can have significant effects auxilin I, which has been reported to be expressed only in on cell growth. These results suggest that GAK plays a pivotal role neurons, GAK is ubiquitously expressed. In vitro GAK, like in regulating not only receptor trafficking but also receptor signal- auxilin I, is known to assist heat shock cognate 70 (Hsc70) in ing and function. uncoating clathrin-coated vesicles (3, 4). Thus, GAK is thought to function in trafficking just after the step regulated by dynamin. Materials and Methods GAK also represents a major portion of the kinase activity in DNA-Based RNA Interference (RNAi) Constructs and Cell Culture. The clathrin-coated vesicles (5). GAK has been reported to phos- retroviral pSuper vector used in the study was the same as that phorylate the ␮2 subunit of adaptor protein (AP)2, as has described in Brummelkamp et al. (26). Selected sequences were AAK1, the protein kinase most closely related to GAK in its submitted to BLAST searches against the human genome sequence catalytic domain (4–9). In the case of AAK1, phosphorylation of to ensure only GAK mRNA is targeted. For generation of stable ␮2 has been shown to have functional consequences in promot- GAK knockdown cells, HeLa (a human cervix epithelioid carci- ing the recruitment of AP2 to internalization motifs found on noma cell line, American Type Culture Collection) or CV1P (an membrane-bound receptors (9). Overexpression of either GAK African green monkey kidney cell line) cells were infected with the or AAK1 is sufficient to impair internalization of the transferrin retroviral pSuper vectors containing either one of two hairpin receptor (4, 7, 10). Thus, GAK may function in both the ultimate constructs capable of generating 19-nt duplex RNAi oligonucleo- disassembly of clathrin-coated vesicles through its auxilin ho- tides corresponding to human GAK sequences starting at the 145th mology domains and in their formation through its kinase base in the coding sequence (denoted 145) or the 525th base domain although there is no direct evidence that GAK can mimic (denoted 525). Cells were cultured in DMEM with 10% FCS, and ͞ AAK1 in regulating vesicle formation (6–9). Because so many 1% penicillin streptomycin in 10% CO2 humidified incubator. kinases play key regulatory roles, it occurred to us that GAK When necessary, 1.5 ␮g/ml puromycin was included for selection. might represent an important regulatory point in receptor trafficking. We were particularly interested to see whether GAK might regulate receptor tyrosine kinases, such as the EGF Abbreviations: GAK, cyclin G-associated kinase; EGF, epidermal growth factor; EGFR, EGF receptor; ERK, extracellular signal-regulated kinase; Hsc70, heat shock cognate 70; RNAi, receptor (EGFR), because this class of receptor is key to normal RNA interference; DAPI, 4Ј,6-diamidino-2-phenylindole; AP, adaptor protein. cell function and transformation, and because the signaling and *To whom correspondence should be addressed. E-mail: thomas࿝[email protected]. trafficking of receptor tyrosine kinases is well characterized. edu. EGFR-mediated signaling results in cell proliferation or differ- † In compliance with Harvard Medical School guidelines on possible conflict of interest, we entiation. Elevated levels or inappropriate activation of the EGFR disclose that T.M.R. has consulting relationships with Upstate Biotechnology and Novartis is associated with increased propensity for cell transformation and Pharmaceuticals. tumor formation (11, 12). Upon ligand stimulation, EGFRs are © 2004 by The National Academy of Sciences of the USA 10296–10301 ͉ PNAS ͉ July 13, 2004 ͉ vol. 101 ͉ no. 28 www.pnas.org͞cgi͞doi͞10.1073͞pnas.0403175101 Downloaded by guest on September 27, 2021 A431 cells (a human epidermoid carcinoma cell line, American chemiluminescence (Amersham Biosciences). The signals were Type Culture Collection) are also used to compare the expression visualized by exposure to Kodak X-Omat blue XB-1 film. level of EGFR. EGF Internalization Assay and Indirect Immunofluorescence. Cells Abs. The following Abs were used: mAb clone 1C2 (anti-GAK, stably expressing a DNA-based RNAi construct targeting GAK Medical & Biological Laboratories); mAb clone MA1 065 (anti- were seeded on eight-well Labtek chamber slides. Twenty-four clathrin heavy chain, Affinity BioReagents, Golden, CO); mAb hours later, cells were serum-starved in DMEM without serum clone14 (anti-EEA1, BD Transduction Laboratories); 4G10 (an- overnight. The next day, cells were incubated with 0.5 ␮g/ml tiphosphotyrosine, Upstate Biotechnology, Lake Placid, NY); mAb tetramethylrhodamine-conjugated EGF (Molecular Probes) for 1 h EGFR (528) Ab (Santa Cruz Biotechnology); polyclonal EGFR on ice and then for 40 min at 37°C. Cells were fixed in 4% (1005) Ab (Santa Cruz Biotechnology); polyclonal phospho-p42͞44 paraformaldehyde, washed with PBS, permeabilized with 0.5% mitogen-activated protein kinase (Thr-202͞Tyr-204) Ab (Cell Sig- Triton X-100 in PBS for 10 min, and blocked with 10% goat serum naling Technology, Beverly, MA); polyclonal p42͞44 Ab (Cell for 1 h. Primary Abs were applied for 1 h and cells were then washed Signaling Technology); polyclonal phospho-ERK5 (Thr-218͞Tyr- with PBS. Cy2-conjugated secondary Abs (The Jackson Labora- 220) Ab (Cell Signaling Technology); polyclonal ERK5 Ab tory) were applied and incubated for 1 h. The same cells were then (Sigma); polyclonal phospho-Akt (Ser-473) or (Thr-308) Abs (Cell counterstained with 4Ј,6-diamidino-2-phenylindole (DAPI; 1 ␮g/ Signaling Technology); and polyclonal Akt Ab (Cell Signaling ml, Sigma) and mounted with Fisher Scientific mounting media. Technology). Cells were visualized with a Zeiss confocal microscope LSM510META͞NLO at ϫ63 magnification and images were cap- Western Blot Analysis and Immunoprecipitation. Cells were seeded in tured by Zeiss confocal microscope software Version 3.2. Ϸ 100-mm dishes and grown to 75% confluence in a 10% CO2 humidified incubator. The next day, cells were serum-starved with BrdUrd Incorporation Assay. Cells grown on chamber slides were DMEM without
Recommended publications
  • Computational Genome-Wide Identification of Heat Shock Protein Genes in the Bovine Genome [Version 1; Peer Review: 2 Approved, 1 Approved with Reservations]
    F1000Research 2018, 7:1504 Last updated: 08 AUG 2021 RESEARCH ARTICLE Computational genome-wide identification of heat shock protein genes in the bovine genome [version 1; peer review: 2 approved, 1 approved with reservations] Oyeyemi O. Ajayi1,2, Sunday O. Peters3, Marcos De Donato2,4, Sunday O. Sowande5, Fidalis D.N. Mujibi6, Olanrewaju B. Morenikeji2,7, Bolaji N. Thomas 8, Matthew A. Adeleke 9, Ikhide G. Imumorin2,10,11 1Department of Animal Breeding and Genetics, Federal University of Agriculture, Abeokuta, Nigeria 2International Programs, College of Agriculture and Life Sciences, Cornell University, Ithaca, NY, 14853, USA 3Department of Animal Science, Berry College, Mount Berry, GA, 30149, USA 4Departamento Regional de Bioingenierias, Tecnologico de Monterrey, Escuela de Ingenieria y Ciencias, Queretaro, Mexico 5Department of Animal Production and Health, Federal University of Agriculture, Abeokuta, Nigeria 6Usomi Limited, Nairobi, Kenya 7Department of Animal Production and Health, Federal University of Technology, Akure, Nigeria 8Department of Biomedical Sciences, Rochester Institute of Technology, Rochester, NY, 14623, USA 9School of Life Sciences, University of KwaZulu-Natal, Durban, 4000, South Africa 10School of Biological Sciences, Georgia Institute of Technology, Atlanta, GA, 30032, USA 11African Institute of Bioscience Research and Training, Ibadan, Nigeria v1 First published: 20 Sep 2018, 7:1504 Open Peer Review https://doi.org/10.12688/f1000research.16058.1 Latest published: 20 Sep 2018, 7:1504 https://doi.org/10.12688/f1000research.16058.1 Reviewer Status Invited Reviewers Abstract Background: Heat shock proteins (HSPs) are molecular chaperones 1 2 3 known to bind and sequester client proteins under stress. Methods: To identify and better understand some of these proteins, version 1 we carried out a computational genome-wide survey of the bovine 20 Sep 2018 report report report genome.
    [Show full text]
  • Gene Targeting Therapies (Roy Alcalay)
    Recent Developments in Gene - Targeted Therapies for Parkinson’s Disease Roy Alcalay, MD, MS Alfred and Minnie Bressler Associate Professor of Neurology Division of Movement Disorders Columbia University Medical Center Disclosures Funding: Dr. Alcalay is funded by the National Institutes of Health, the DOD, the Michael J. Fox Foundation and the Parkinson’s Foundation. Dr. Alcalay receives consultation fees from Genzyme/Sanofi, Restorbio, Janssen, and Roche. Gene Localizations Identified in PD Gene Symbol Protein Transmission Chromosome PARK1 SNCA α-synuclein AD 4q22.1 PARK2 PRKN parkin (ubiquitin ligase) AR 6q26 PARK3 ? ? AD 2p13 PARK4 SNCA triplication α-synuclein AD 4q22.1 PARK5 UCH-L1 ubiquitin C-terminal AD 4p13 hydrolase-L1 PARK6 PINK1 PTEN-induced kinase 1 AR 1p36.12 PARK7 DJ-1 DJ-1 AR 1p36.23 PARK8 LRRK2 leucine rich repeat kinase 2 AD 12q12 PARK9 ATP13A2 lysosomal ATPase AR 1p36.13 PARK10 ? ? (Iceland) AR 1p32 PARK11 GIGYF2 GRB10-interacting GYF protein 2 AD 2q37.1 PARK12 ? ? X-R Xq21-q25 PARK13 HTRA2 serine protease AD 2p13.1 PARK14 PLA2G6 phospholipase A2 (INAD) AR 22q13.1 PARK15 FBXO7 F-box only protein 7 AR 22q12.3 PARK16 ? Discovered by GWAS ? 1q32 PARK17 VPS35 vacuolar protein sorting 35 AD 16q11.2 PARK18 EIF4G1 initiation of protein synth AD 3q27.1 PARK19 DNAJC6 auxilin AR 1p31.3 PARK20 SYNJ1 synaptojanin 1 AR 21q22.11 PARK21 DNAJC13 8/RME-8 AD 3q22.1 PARK22 CHCHD2 AD 7p11.2 PARK23 VPS13C AR 15q22 Gene Localizations Identified in PD Disorder Symbol Protein Transmission Chromosome PD GBA β-glucocerebrosidase AD 1q21 SCA2
    [Show full text]
  • University of Groningen the Human HSP70/HSP40 Chaperone Family
    University of Groningen The human HSP70/HSP40 chaperone family Hageman, Jurre IMPORTANT NOTE: You are advised to consult the publisher's version (publisher's PDF) if you wish to cite from it. Please check the document version below. Document Version Publisher's PDF, also known as Version of record Publication date: 2008 Link to publication in University of Groningen/UMCG research database Citation for published version (APA): Hageman, J. (2008). The human HSP70/HSP40 chaperone family: a study on its capacity to combat proteotoxic stress. s.n. Copyright Other than for strictly personal use, it is not permitted to download or to forward/distribute the text or part of it without the consent of the author(s) and/or copyright holder(s), unless the work is under an open content license (like Creative Commons). The publication may also be distributed here under the terms of Article 25fa of the Dutch Copyright Act, indicated by the “Taverne” license. More information can be found on the University of Groningen website: https://www.rug.nl/library/open-access/self-archiving-pure/taverne- amendment. Take-down policy If you believe that this document breaches copyright please contact us providing details, and we will remove access to the work immediately and investigate your claim. Downloaded from the University of Groningen/UMCG research database (Pure): http://www.rug.nl/research/portal. For technical reasons the number of authors shown on this cover page is limited to 10 maximum. Download date: 30-09-2021 CHAPTER 1 Introduction - Structural and functional diversities between members of the human HSPH, HSPA and DNAJ chaperone families Jurre Hageman and Harm H.
    [Show full text]
  • Supplementary Information Material and Methods
    MCT-11-0474 BKM120: a potent and specific pan-PI3K inhibitor Supplementary Information Material and methods Chemicals The EGFR inhibitor NVP-AEE788 (Novartis), the Jak inhibitor I (Merck Calbiochem, #420099) and anisomycin (Alomone labs, # A-520) were prepared as 50 mM stock solutions in 100% DMSO. Doxorubicin (Adriablastin, Pfizer), EGF (Sigma Ref: E9644), PDGF (Sigma, Ref: P4306) and IL-4 (Sigma, Ref: I-4269) stock solutions were prepared as recommended by the manufacturer. For in vivo administration: Temodal (20 mg Temozolomide capsules, Essex Chemie AG, Luzern) was dissolved in 4 mL KZI/glucose (20/80, vol/vol); Taxotere was bought as 40 mg/mL solution (Sanofi Aventis, France), and prepared in KZI/glucose. Antibodies The primary antibodies used were as follows: anti-S473P-Akt (#9271), anti-T308P-Akt (#9276,), anti-S9P-GSK3β (#9336), anti-T389P-p70S6K (#9205), anti-YP/TP-Erk1/2 (#9101), anti-YP/TP-p38 (#9215), anti-YP/TP-JNK1/2 (#9101), anti-Y751P-PDGFR (#3161), anti- p21Cip1/Waf1 (#2946), anti-p27Kip1 (#2552) and anti-Ser15-p53 (#9284) antibodies were from Cell Signaling Technologies; anti-Akt (#05-591), anti-T32P-FKHRL1 (#06-952) and anti- PDGFR (#06-495) antibodies were from Upstate; anti-IGF-1R (#SC-713) and anti-EGFR (#SC-03) antibodies were from Santa Cruz; anti-GSK3α/β (#44610), anti-Y641P-Stat6 (#611566), anti-S1981P-ATM (#200-301), anti-T2609 DNA-PKcs (#GTX24194) and anti- 1 MCT-11-0474 BKM120: a potent and specific pan-PI3K inhibitor Y1316P-IGF-1R were from Bio-Source International, Becton-Dickinson, Rockland, GenTex and internal production, respectively. The 4G10 antibody was from Millipore (#05-321MG).
    [Show full text]
  • Mitochondrial Quality Control in Neurodegenerative Diseases: Focus on Parkinson’S Disease and Huntington’S Disease
    ADVERTIMENT. Lʼaccés als continguts dʼaquesta tesi queda condicionat a lʼacceptació de les condicions dʼús establertes per la següent llicència Creative Commons: http://cat.creativecommons.org/?page_id=184 ADVERTENCIA. El acceso a los contenidos de esta tesis queda condicionado a la aceptación de las condiciones de uso establecidas por la siguiente licencia Creative Commons: http://es.creativecommons.org/blog/licencias/ WARNING. The access to the contents of this doctoral thesis it is limited to the acceptance of the use conditions set by the following Creative Commons license: https://creativecommons.org/licenses/?lang=en Mitochondrial quality control in neurodegenerative diseases: focus on Parkinson’s disease and Huntington’s disease TESI DOCTORAL 2018 Programa de Doctorat en Neurociències Institut de Neurociències Tesi realitzada al laboratori de Malalties Neurodegeenratives de l’Institut de Recerca de la Vall d’Hebron (VHIR) Doctorand Director Tutor Sandra Franco Iborra Miquel Vila Bover José Rodríguez Álvarez Co-directora Co-directora Celine Perier Marta Martínez Vicente i AGRAÏMENTS En primer lloc vull agraïr al Miquel Vila per l’oportunitat que em va donar de començar a fer la tesi doctoral al seu lab. Gràcies per tenir sempre la porta oberta del teu despatx, per la confiança dipositada en mi i per tot el que m’has ensenyat durant tots aquests anys. A més, he tingut la sort de tenir no només un director de tesis sinó tres! Celine muchas gracias por estar siempre ahí, por ensenyarme tu manera de hacer ciencia (que me encanta!) y por ser siempre tan positiva. En mi manera de trabajar hay un poquito de ti y espero ir pasando este conocimiento a los demás porque en todo laboratorio debería ser obligatorio que hubiera alguien como tu.
    [Show full text]
  • Profiling Data
    Compound Name DiscoveRx Gene Symbol Entrez Gene Percent Compound Symbol Control Concentration (nM) JNK-IN-8 AAK1 AAK1 69 1000 JNK-IN-8 ABL1(E255K)-phosphorylated ABL1 100 1000 JNK-IN-8 ABL1(F317I)-nonphosphorylated ABL1 87 1000 JNK-IN-8 ABL1(F317I)-phosphorylated ABL1 100 1000 JNK-IN-8 ABL1(F317L)-nonphosphorylated ABL1 65 1000 JNK-IN-8 ABL1(F317L)-phosphorylated ABL1 61 1000 JNK-IN-8 ABL1(H396P)-nonphosphorylated ABL1 42 1000 JNK-IN-8 ABL1(H396P)-phosphorylated ABL1 60 1000 JNK-IN-8 ABL1(M351T)-phosphorylated ABL1 81 1000 JNK-IN-8 ABL1(Q252H)-nonphosphorylated ABL1 100 1000 JNK-IN-8 ABL1(Q252H)-phosphorylated ABL1 56 1000 JNK-IN-8 ABL1(T315I)-nonphosphorylated ABL1 100 1000 JNK-IN-8 ABL1(T315I)-phosphorylated ABL1 92 1000 JNK-IN-8 ABL1(Y253F)-phosphorylated ABL1 71 1000 JNK-IN-8 ABL1-nonphosphorylated ABL1 97 1000 JNK-IN-8 ABL1-phosphorylated ABL1 100 1000 JNK-IN-8 ABL2 ABL2 97 1000 JNK-IN-8 ACVR1 ACVR1 100 1000 JNK-IN-8 ACVR1B ACVR1B 88 1000 JNK-IN-8 ACVR2A ACVR2A 100 1000 JNK-IN-8 ACVR2B ACVR2B 100 1000 JNK-IN-8 ACVRL1 ACVRL1 96 1000 JNK-IN-8 ADCK3 CABC1 100 1000 JNK-IN-8 ADCK4 ADCK4 93 1000 JNK-IN-8 AKT1 AKT1 100 1000 JNK-IN-8 AKT2 AKT2 100 1000 JNK-IN-8 AKT3 AKT3 100 1000 JNK-IN-8 ALK ALK 85 1000 JNK-IN-8 AMPK-alpha1 PRKAA1 100 1000 JNK-IN-8 AMPK-alpha2 PRKAA2 84 1000 JNK-IN-8 ANKK1 ANKK1 75 1000 JNK-IN-8 ARK5 NUAK1 100 1000 JNK-IN-8 ASK1 MAP3K5 100 1000 JNK-IN-8 ASK2 MAP3K6 93 1000 JNK-IN-8 AURKA AURKA 100 1000 JNK-IN-8 AURKA AURKA 84 1000 JNK-IN-8 AURKB AURKB 83 1000 JNK-IN-8 AURKB AURKB 96 1000 JNK-IN-8 AURKC AURKC 95 1000 JNK-IN-8
    [Show full text]
  • Application of a MYC Degradation
    SCIENCE SIGNALING | RESEARCH ARTICLE CANCER Copyright © 2019 The Authors, some rights reserved; Application of a MYC degradation screen identifies exclusive licensee American Association sensitivity to CDK9 inhibitors in KRAS-mutant for the Advancement of Science. No claim pancreatic cancer to original U.S. Devon R. Blake1, Angelina V. Vaseva2, Richard G. Hodge2, McKenzie P. Kline3, Thomas S. K. Gilbert1,4, Government Works Vikas Tyagi5, Daowei Huang5, Gabrielle C. Whiten5, Jacob E. Larson5, Xiaodong Wang2,5, Kenneth H. Pearce5, Laura E. Herring1,4, Lee M. Graves1,2,4, Stephen V. Frye2,5, Michael J. Emanuele1,2, Adrienne D. Cox1,2,6, Channing J. Der1,2* Stabilization of the MYC oncoprotein by KRAS signaling critically promotes the growth of pancreatic ductal adeno- carcinoma (PDAC). Thus, understanding how MYC protein stability is regulated may lead to effective therapies. Here, we used a previously developed, flow cytometry–based assay that screened a library of >800 protein kinase inhibitors and identified compounds that promoted either the stability or degradation of MYC in a KRAS-mutant PDAC cell line. We validated compounds that stabilized or destabilized MYC and then focused on one compound, Downloaded from UNC10112785, that induced the substantial loss of MYC protein in both two-dimensional (2D) and 3D cell cultures. We determined that this compound is a potent CDK9 inhibitor with a previously uncharacterized scaffold, caused MYC loss through both transcriptional and posttranslational mechanisms, and suppresses PDAC anchorage- dependent and anchorage-independent growth. We discovered that CDK9 enhanced MYC protein stability 62 through a previously unknown, KRAS-independent mechanism involving direct phosphorylation of MYC at Ser .
    [Show full text]
  • The Number of Genes
    Table S1. The numbers of KD genes in each KD time The number The number The number The number Cell lines of genes of genes of genes of genes (96h) (120h) (144h) PC3 3980 3822 128 1725 A549 3724 3724 0 0 MCF7 3688 3471 0 1837 HT29 3665 3665 0 0 A375 3826 3826 0 0 HA1E 3801 3801 0 0 VCAP 4134 34 4121 0 HCC515 3522 3522 0 0 Table S2. The predicted results in the PC3 cell line on the LINCS II data id target rank A07563059 ADRB2 48 A12896037 ADRA2C 91 A13021932 YES1 77 PPM1B;PPP1CC;PPP2CA; A13254067 584;1326;297;171;3335 PTPN1;PPP2R5A A16347691 GMNN 2219 PIK3CB;MTOR;PIK3CA;PIK A28467416 18;10;9;13;8 3CG;PIK3CD A28545468 EHMT2;MAOB 14;67 A29520968 HSPB1 1770 A48881734 EZH2 1596 A52922642 CACNA1C 201 A64553394 ADRB2 155 A65730376 DOT1L 3764 A82035391 JUN 378 A82156122 DPP4 771 HRH1;HTR2C;CHRM3;CH A82772293 2756;2354;2808;2367 RM1 A86248581 CDA 1785 A92800748 TEK 459 A93093700 LMNA 1399 K00152668 RARB 105 K01577834 ADORA2A 525 K01674964 HRH1;BLM 31;1314 K02314383 AR 132 K03194791 PDE4D 30 K03390685 MAP2K1 77 K06762493 GMNN;APEX1 1523;2360 K07106112 ERBB4;ERBB2;EGFR 497;60;23 K07310275 AKT1;MTOR;PIK3CA 13;12;1 K07753030 RGS4;BLM 3736;3080 K08109215 BRD2;BRD3;BRD4 1413;2786;3 K08248804 XIAP 88 K08586861 TBXA2R;MBNL1 297;3428 K08832567 GMNN;CA12 2544;50 LMNA;NFKB1;APEX1;EH K08976401 1322;341;3206;123 MT2 K09372874 IMPDH2 232 K09711437 PLA2G2A 59 K10859802 GPR119 214 K11267252 RET;ALK 395;760 K12609457 LMNA 907 K13094524 BRD4 7 K13662825 CDK4;CDK9;CDK5;CDK1 34;58;13;18 K14704277 LMNA;BLM 1697;1238 K14870255 AXL 1696 K15170068 MAN2B1 1756 K15179879
    [Show full text]
  • Lipid Metabolic Reprogramming: Role in Melanoma Progression and Therapeutic Perspectives
    cancers Review Lipid metabolic Reprogramming: Role in Melanoma Progression and Therapeutic Perspectives 1, 1, 1 2 1 Laurence Pellerin y, Lorry Carrié y , Carine Dufau , Laurence Nieto , Bruno Ségui , 1,3 1, , 1, , Thierry Levade , Joëlle Riond * z and Nathalie Andrieu-Abadie * z 1 Centre de Recherches en Cancérologie de Toulouse, Equipe Labellisée Fondation ARC, Université Fédérale de Toulouse Midi-Pyrénées, Université Toulouse III Paul-Sabatier, Inserm 1037, 2 avenue Hubert Curien, tgrCS 53717, 31037 Toulouse CEDEX 1, France; [email protected] (L.P.); [email protected] (L.C.); [email protected] (C.D.); [email protected] (B.S.); [email protected] (T.L.) 2 Institut de Pharmacologie et de Biologie Structurale, CNRS, Université Toulouse III Paul-Sabatier, UMR 5089, 205 Route de Narbonne, 31400 Toulouse, France; [email protected] 3 Laboratoire de Biochimie Métabolique, CHU Toulouse, 31059 Toulouse, France * Correspondence: [email protected] (J.R.); [email protected] (N.A.-A.); Tel.: +33-582-7416-20 (J.R.) These authors contributed equally to this work. y These authors jointly supervised this work. z Received: 15 September 2020; Accepted: 23 October 2020; Published: 27 October 2020 Simple Summary: Melanoma is a devastating skin cancer characterized by an impressive metabolic plasticity. Melanoma cells are able to adapt to the tumor microenvironment by using a variety of fuels that contribute to tumor growth and progression. In this review, the authors summarize the contribution of the lipid metabolic network in melanoma plasticity and aggressiveness, with a particular attention to specific lipid classes such as glycerophospholipids, sphingolipids, sterols and eicosanoids.
    [Show full text]
  • Structure of an Auxilin-Bound Clathrin Coat and Its Implications for The
    letters to nature common drug target27, suggesting that the spindle-associated 24. Chi, N. W. & Lodish, H. F. Tankyrase is a golgi-associated mitogen-activated protein kinase substrate A that interacts with IRAP in GLUT4 vesicles. J. Biol. Chem. 275, 38437–38444 (2000). PARPs are potential cancer drug targets. 25. Rouleau, M., Aubin, R. A. & Poirier, G. G. Poly(ADP-ribosyl)ated chromatin domains: access granted. J. Cell Sci. 117, 815–825 (2004). Methods 26. Pickett-Heaps, J. D., Forer, A. & Spurck, T. Traction fibre: toward a “tensegral” model of the spindle. Cell Motil. Cytoskel. 37, 1–6 (1997). Imaging and antibodies 27. Troll, W., Garte, S. & Frenkel, K. Suppression of tumor promotion by inhibitors of poly(ADP)ribose Cycled Xenopus egg extract spindles were assembled as described12 with or without formation. Basic Life Sci. 52, 225–232 (1990). X-rhodamine-labelled or Alexa-488-labelled tubulin, and isolated through 40% glycerol 28. Tirnauer, J. S., Salmon, E. D. & Mitchison, T. J. Microtubule plus-end dynamics in Xenopus egg extract BRB80. For staining of non-fixed spindles, isolated spindles were processed for spindles. Mol. Biol. Cell 15, 1776–1784 (2004). immunofluorescence in solutions containing 5% glycerol BRB80. For 29. Lin, W., Ame, J. C., Aboul-Ela, N., Jacobson, E. L. & Jacobson, M. K. Isolation and characterization of immunofluorescence and immunoblotting, polyclonal rabbit LP96-10 IgG was purchased the cDNA encoding bovine poly(ADP-ribose) glycohydrolase. J. Biol. Chem. 272, 11895–11901 from BD Biosciences, polyclonal chicken IgYanti-PAR antibodies from Tulip Biolabs, and (1997). monoclonal 10H from Trevigen. All anti-PAR antibodies were pre-adsorbed against BSA transferred to nitrocellulose.
    [Show full text]
  • The HSP70 Chaperone Machinery: J Proteins As Drivers of Functional Specificity
    REVIEWS The HSP70 chaperone machinery: J proteins as drivers of functional specificity Harm H. Kampinga* and Elizabeth A. Craig‡ Abstract | Heat shock 70 kDa proteins (HSP70s) are ubiquitous molecular chaperones that function in a myriad of biological processes, modulating polypeptide folding, degradation and translocation across membranes, and protein–protein interactions. This multitude of roles is not easily reconciled with the universality of the activity of HSP70s in ATP-dependent client protein-binding and release cycles. Much of the functional diversity of the HSP70s is driven by a diverse class of cofactors: J proteins. Often, multiple J proteins function with a single HSP70. Some target HSP70 activity to clients at precise locations in cells and others bind client proteins directly, thereby delivering specific clients to HSP70 and directly determining their fate. In their native cellular environment, polypeptides are participates in such diverse cellular functions. Their constantly at risk of attaining conformations that pre- functional diversity is remarkable considering that vent them from functioning properly and/or cause them within and across species, HSP70s have high sequence to aggregate into large, potentially cytotoxic complexes. identity. They share a single biochemical activity: an Molecular chaperones guide the conformation of proteins ATP-dependent client-binding and release cycle com- throughout their lifetime, preventing their aggregation bined with client protein recognition, which is typi- by protecting interactive surfaces against non-productive cally rather promiscuous. This apparent conundrum interactions. Through such inter actions, molecular chap- is resolved by the fact that HSP70s do not work alone, erones aid in the folding of nascent proteins as they are but rather as ‘HSP70 machines’, collaborating with synthesized by ribosomes, drive protein transport across and being regulated by several cofactors.
    [Show full text]
  • GAK (1C2): Sc-56903
    SANTA CRUZ BIOTECHNOLOGY, INC. GAK (1C2): sc-56903 The Power to Question BACKGROUND SOURCE Cyclins are the regulatory subunits of Cdc2 p34 and related cyclin-dependent GAK (1C2) is a mouse monoclonal antibody raised against amino acids kinases (Cdks) which play critical roles in the control of cell cycle progression. 1-1305 of GAK of rat origin. The catalytic subunit for cyclin A and B is Cdc2 p34 kinase. The Cdc2-cyclin This product has been manufactured by MBL International Corporation. B complex controls the G2 to M transition, whereas Cdc2-cyclin A regulates S phase progression. The G to S transition, however, appears to be controlled 1 PRODUCT by the G1 cyclins. Cyclin D1 accumulates during G1 and associates with Cdk2, Each vial contains 100 µg IgG in 1.0 ml of PBS with < 0.1% sodium azide, Cdk4 and Cdk5. Cyclin E and Cdk2 interact during the G1 to S transition. 1 Cyclin G contains a typical N-terminal cyclin box and a C-terminal domain 0.1% gelatin and 5% glycerol. sequence homologous to the tyrosine phosphorylation site of the epidermal growth factor receptor. Cyclin G expression is induced within three hours after APPLICATIONS growth stimulation and remains elevated with no apparent cell cycle depen- GAK (1C2) is recommended for detection of GAK of mouse, rat and human dency. A serine/threonine kinase, designated GAK for cyclin G associated origin by Western Blotting (starting dilution 1:200, dilution range 1:100- kinase, has been identified. GAK has been shown to bind directly to cyclin G 1:1000).
    [Show full text]